Pure Global

Test for Creatine Kinase Isoenzyme-MB - India CDSCO Medical Device Registration

Test for Creatine Kinase Isoenzyme-MB is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000203_3fbcd8564541c23d2ee9876d86b51e3f_09ea8b9f7abb49855dd50048cc95ccb1. This device is marketed under the brand name QDx Instacheck™ Cortisol. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Test for Creatine Kinase Isoenzyme-MB
UID: IMP/MD/2018/000203_3fbcd8564541c23d2ee9876d86b51e3f_09ea8b9f7abb49855dd50048cc95ccb1

Brand Name

QDx Instacheck™ Cortisol

Device Class

Class B

Approving Authority

CDSCO

Product Information

QDx Instacheck™ CK-MB along with QDx Instacheck™ Reader is fluorescence Immunoassay (QDx Instacheck™ Cortisol) for the quantitative determination of Creatine Kinase Isoenzyme-MB (QDx Instacheck™ Cortisol) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardiac infarction (QDx Instacheck™ Cortisol) and acute coronary syndrome (QDx Instacheck™ Cortisol)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing